Persistent Chemosensitivity to Platinum and/or Paclitaxel in Metastatic Endometrial Cancer

Author： Markman M. Kennedy A. Webster K. Kulp B. Peterson G. Belinson J.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.73, Iss.3, 1999-06, pp. : 422-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Single Agent Paclitaxel in the Treatment of Unresectable and/or Metastatic Pancreatic Adenocarcinoma

By Gebbia N. Gebbia V.

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1822-1823

Elsevier

Access to resources Recommend Favorite

Association between CHFR methylation and chemosensitivity of paclitaxel in advanced gastric cancer

By Wang Mingming Shen Lin Deng Dajun

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-2

Humana Press, Inc

Access to resources Recommend Favorite

RNA interference targeting CHFR enhances taxol chemosensitivity in endometrial cancer cells

By Li Xiaomao Wang Xiaoyun Yang Yuebo Xu Chengfang Shen Huimin

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 248-254

Spandidos Publications

Access to resources Recommend Favorite

Topotecan in Platinum- and Paclitaxel-Resistant Ovarian Cancer

By Swisher E.M. Mutch D.G. Rader J.S. Elbendary A. Herzog T.J.

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 480-486

Elsevier

Access to resources Recommend Favorite

Case report of nab-paclitaxel in metastatic pancreatic cancer

By Haslbauer Ferdinand

memo - Magazine of European Medical Oncology, Vol. 7, Iss. 1, 2014-02 ,pp. : 39-42

Springer Publishing Company

Access to resources Recommend Favorite